A U.S. judge on Friday refused to dismiss a $6.4 billion lawsuit accusing Bristol Myers Squibb Co. of delaying its Breyanzi cancer drug to avoid payments to shareholders of the former Celgene Corp., which the drugmaker bought for $80.3 billion in 2019.
Posts
Meltmedia, an award-winning provider of digital strategy, design, and development services to the life science industry, has been acquired by Evoke, a global brand, experience, and communications platform, purpose-built to make health more human.
Pharmaceutical powerhouse AstraZeneca appears to have taken an interest in the company’s London-based partner Mereo BioPharma and may be considering a buyout, according to circulating speculations first reported by The Times UK.
Med Ad News caught up with Fishawack Health CEO Jon Koch and Avalere Health President Elizabeth Carpenter to discuss the deal and why it took place, and what Avalere brings to Fishawack.
